|
|
||||||||
9V
2 T Cells by NKG2D1




* Institut für Virologie und Immunobiologie,
Medizinische Poliklinik, Julius-Maximilians Universität, Würzburg, Germany;
Institut für Immunologie, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany; and
Institut für Zellbiologie, Eberhard-Karls-Universität Tübingen, Tübingen, Germany
Human V
9V
2 T cells recognize phosphorylated nonpeptide Ags (so called phosphoantigens), certain tumor cells, and cells treated with aminobisphosphonates. NKG2D, an activating receptor for NK cells, has been described as a potent costimulatory receptor in the Ag-specific activation of 
and CD8 T cells. This study provides evidence that V
9V
2 T cells may also be directly activated by NKG2D. Culture of PBMC with immobilized NKG2D-specific mAb or NKG2D ligand MHC class I related protein A (MICA) induces the up-regulation of CD69 and CD25 in NK and V
9V
2 but not in CD8 T cells. Furthermore, NKG2D triggers the production of TNF-
but not of IFN-
, as well as the release of cytolytic granules by V
9V
2 T cells. Purified V
9V
2 T cells kill MICA-transfected RMA mouse cells but not control cells. Finally, DAP10, which mediates NKG2D signaling in human NK cells, was detected in resting and activated V
9V
2 T cells. These remarkable similarities in NKG2D function in NK and V
9V
2 T cells may open new perspectives for V
9V
2 T cell-based immunotherapy, e.g., by Ag-independent killing of NKG2D ligand-expressing tumors.
This article has been cited by other articles:
![]() |
W. Cao, X. Xi, Z. Hao, W. Li, Y. Kong, L. Cui, C. Ma, D. Ba, and W. He RAET1E2, a Soluble Isoform of the UL16-binding Protein RAET1E Produced by Tumor Cells, Inhibits NKG2D-mediated NK Cytotoxicity J. Biol. Chem., June 29, 2007; 282(26): 18922 - 18928. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Saikali, J. P. Antel, J. Newcombe, Z. Chen, M. Freedman, M. Blain, R. Cayrol, A. Prat, J. A. Hall, and N. Arbour NKG2D-Mediated Cytotoxicity toward Oligodendrocytes Suggests a Mechanism for Tissue Injury in Multiple Sclerosis J. Neurosci., January 31, 2007; 27(5): 1220 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kabelitz, D. Wesch, and W. He Perspectives of {gamma}{delta} T Cells in Tumor Immunology Cancer Res., January 1, 2007; 67(1): 5 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Caccamo, F. Dieli, D. Wesch, H. Jomaa, and M. Eberl Sex-specific phenotypical and functional differences in peripheral human V{gamma}9/V{delta}2 T cells J. Leukoc. Biol., April 1, 2006; 79(4): 663 - 666. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |